BCTX BriaCell Therapeutics Corp. - Common Shares
BCTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BCTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
BCTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 1 20.0%
- Buy 3 60.0%
- Hold 1 20.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-2.58 | $-4.89 | 2.3% |
| Sept. 30, 2025 | $-55.49 | $-12.23 | -43.3% |
| June 30, 2025 | $-16.40 | $-17.78 | 1.4% |
| March 31, 2025 | $-23.30 | $-19.59 | -3.7% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BCTX | — | — | — | — | — | — |
| EDSA | $18M | — | — | — | -51.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 20 filers · $1.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-1 vs prior Q) | 0 (-3 vs prior Q) | 4 (+3 vs prior Q) | 1 (-2 vs prior Q) | +121K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Cable Car Capital, LP | $702,500 | 216,821 | 48.58% | Shares |
| SABBY MANAGEMENT, LLC | $261,536 | 80,721 | 18.09% | Shares |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $210,600 | 65,000 | 14.56% | Shares |
| UBS Group AG | $141,400 | 43,642 | 9.78% | Shares |
| JANE STREET GROUP, LLC | $49,099 | 15,154 | 3.40% | Shares |
| LuminArx Capital Management LP | $48,600 | 15,000 | 3.36% | Shares |
| LuminArx Capital Management LP | $22,250 | 25,000 | 1.54% | Call option |
| NATIONAL BANK OF CANADA /FI/ | $5,796 | 1,803 | 0.40% | Shares |
| MORGAN STANLEY | $1,983 | 612 | 0.14% | Shares |
| Federation des caisses Desjardins du Quebec | $1,444 | 450 | 0.10% | Shares |
| Allworth Financial LP | $324 | 100 | 0.02% | Shares |
| SSA SWISS ADVISORS AG | $121 | 37 | 0.01% | Shares |
| HRT FINANCIAL LP | $113 | 34,904 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $110 | 34 | 0.01% | Shares |
| TD Waterhouse Canada Inc. | $66 | 19 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $52 | 16 | 0.00% | Shares |
| HHM Wealth Advisors, LLC | $20 | 6 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $3 | 1 | 0.00% | Shares |
| FNY Investment Advisers, LLC | $0 | 10 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 100 | 0.00% | Shares |
Company insiders 3 insiders · 2 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Williams V. Williams | President, CEO | Dec. 23, 2022 P | — | 0 | 0 | $0 |
| Jamieson Bondarenko | Chairman | Dec. 28, 2022 P | 169,856 | 0 | 0 | $0 |
| Marc Lustig | Director | May 14, 2024 P | 2,542,935 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Marc Lustig, L5 Capital Inc. ×4 filings | Dec. 12, 2024 | — | Initial filing | Passive investment | SEC |
| Ault Global Holdings, Inc. ×2 filings | Sept. 20, 2021 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.